# Professional Summary Dr. Jasjeet Singh Wasir is a distinguished endocrinologist and diabetologist currently serving as Director at the Division of Endocrinology and Diabetes at the prestigious Medanta The Medicity in Gurugram, India. With nearly 10 years of dedicated experience in the field of diabetes and metabolic diseases, Dr. Wasir brings a wealth of clinical expertise to patients seeking advanced care for complex endocrine and metabolic conditions. Dr. Wasir received his formal medical training from some of India's most esteemed institutions, including the All India Institute of Medical Sciences (AIIMS), Maulana Azad Medical College, and University College of Medical Sciences. He serves as a primary faculty member at the Center for Advanced Diabetes Therapy and Technology and is actively spearheading the weight management programme at Medanta under the guidance of Dr. Ambrish Mithal. His areas of clinical focus span weight management, diabetes care, heart attack risk factor assessment and control, and advanced therapeutic approaches for complicated diabetes and special metabolic conditions. Dr. Wasir is also a prolific researcher with numerous publications in high-impact international and national medical journals. He has presented his original work at both national and international forums, reflecting his commitment to advancing the science of endocrinology and diabetes care.
- Endocrinology & Diabetology
- Type 2 Diabetes
- Type 1 Diabetes (Specialist Management)
- Metabolic Syndrome Treatment
- Insulin Resistance Disorders
- Thyroid Nodules
- Polycystic Ovary Syndrome (PCOS)
- M.B.B.S. — Medical degree
- M.D. (Internal Medicine) — Postgraduate specialization
- Formal medical training from All India Institute of Medical Sciences (AIIMS)
- Training at Maulana Azad Medical College
- Training at University College of Medical Sciences
- Medanta The Medicity, Gurugram
- Medanta Mediclinic Golf Course
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
